| Product Code: ETC8539711 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Haemophilia Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Haemophilia Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Haemophilia Market - Industry Life Cycle |
3.4 Netherlands Haemophilia Market - Porter's Five Forces |
3.5 Netherlands Haemophilia Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Netherlands Haemophilia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Netherlands Haemophilia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Netherlands Haemophilia Market Revenues & Volume Share, By Patient, 2021 & 2031F |
3.9 Netherlands Haemophilia Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 Netherlands Haemophilia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Netherlands Haemophilia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Haemophilia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about haemophilia and its treatment options in the Netherlands |
4.2.2 Technological advancements in haemophilia treatments leading to improved patient outcomes |
4.2.3 Growing healthcare expenditure and government initiatives to support haemophilia patients |
4.3 Market Restraints |
4.3.1 High cost of haemophilia treatments and therapies |
4.3.2 Limited access to specialized care and treatment centers in certain regions of the Netherlands |
5 Netherlands Haemophilia Market Trends |
6 Netherlands Haemophilia Market, By Types |
6.1 Netherlands Haemophilia Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Haemophilia Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Netherlands Haemophilia Market Revenues & Volume, By Medication, 2021- 2031F |
6.1.4 Netherlands Haemophilia Market Revenues & Volume, By Desmopressin, 2021- 2031F |
6.1.5 Netherlands Haemophilia Market Revenues & Volume, By Emicizumab, 2021- 2031F |
6.1.6 Netherlands Haemophilia Market Revenues & Volume, By Anti-fibrinolytics, 2021- 2031F |
6.1.7 Netherlands Haemophilia Market Revenues & Volume, By ITI Therapy, 2021- 2031F |
6.1.8 Netherlands Haemophilia Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.9 Netherlands Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Netherlands Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Haemophilia Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Haemophilia Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Netherlands Haemophilia Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 Netherlands Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Haemophilia Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Haemophilia Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.3.3 Netherlands Haemophilia Market Revenues & Volume, By Genetic Tests, 2021- 2031F |
6.3.4 Netherlands Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Netherlands Haemophilia Market, By Patient |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Haemophilia Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4.3 Netherlands Haemophilia Market Revenues & Volume, By Adult, 2021- 2031F |
6.5 Netherlands Haemophilia Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Haemophilia Market Revenues & Volume, By Haemophilia A, 2021- 2031F |
6.5.3 Netherlands Haemophilia Market Revenues & Volume, By Haemophilia B, 2021- 2031F |
6.5.4 Netherlands Haemophilia Market Revenues & Volume, By Haemophilia C, 2021- 2031F |
6.5.5 Netherlands Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Netherlands Haemophilia Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Netherlands Haemophilia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Netherlands Haemophilia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Netherlands Haemophilia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 Netherlands Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Netherlands Haemophilia Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Netherlands Haemophilia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Netherlands Haemophilia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Netherlands Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Netherlands Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Haemophilia Market Import-Export Trade Statistics |
7.1 Netherlands Haemophilia Market Export to Major Countries |
7.2 Netherlands Haemophilia Market Imports from Major Countries |
8 Netherlands Haemophilia Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for haemophilia patients |
8.2 Percentage of haemophilia patients with access to comprehensive care facilities |
8.3 Number of clinical trials and research studies focused on haemophilia treatments |
8.4 Patient satisfaction scores with haemophilia treatment services provided |
9 Netherlands Haemophilia Market - Opportunity Assessment |
9.1 Netherlands Haemophilia Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Netherlands Haemophilia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Netherlands Haemophilia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Netherlands Haemophilia Market Opportunity Assessment, By Patient, 2021 & 2031F |
9.5 Netherlands Haemophilia Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 Netherlands Haemophilia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Netherlands Haemophilia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Haemophilia Market - Competitive Landscape |
10.1 Netherlands Haemophilia Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Haemophilia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here